1 / 7

Precision Medicine Market forecast to witness growth of 10.5% from 2016 to 2023

Get more details @ http://bit.ly/2ekRPfD <br>Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.

jueekate
Download Presentation

Precision Medicine Market forecast to witness growth of 10.5% from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Precision Medicine Market forecast to reach $87.7bn by 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Precision Medicine Market: • Global Precision Medicine Market size is driven by growing occurrence of cancer and increase in cancer prone geriatric population all across the globe. • Global Precision Medicine Market size was more than $39.1 billion for 2015 and is predicted to register 10.51% of CAGR during forecast timeframe. • It is innovative procedure for treating and preventing chronic ailments depending upon changes in individual genes and other lifestyle features. New approach helps doctors properly assess ailment risk and predict optimal treatment. • The industry is segmented into different technologies like gene sequencing, companion diagnostics, big data analytics, bioinformatics and drug discovery. • Gene sequencing segment size was more than $8.1 billion for 2015. Current FDA guidelines on next -generation sequencing dependent tests takes into consideration individual differences in genes of various persons, environments and life patterns while creating new type of healthcare.

  3. Continued... • Companion diagnostics segment has acquired importance owing to rising concerns about rates of drug failures. Further, the segment is expanding at rapid pace owing to rise in financial support and approvals by government. • Heavy throughput omics techniques applied in biological and basic research are predicted to propel bioinformatics segment growth. Out of all omics techniques next-generation technique is predicted to create key impact on the segment growth. • Drug discovery technique contributed more than $9 billion for 2015 and is predicted to register CAGR of 8.31% during forecast timeframe. • Global industry is segmented into various applications like respiratory application, oncology application, Immunology application and central nervous system (CNS) application. • Oncology application contributed more than 30.1% of precision medicine market share for 2015 and is predicted to record CAGR of 10.91% during forecast timeframe.

  4. Continued... • CNS application contributed more than $9.1 billion for 2015. Neuroscience therapeutics has been utilizing the approach for long duration. • Global industry was segmented into key geographical regions like North America, MEA, Europe, APAC and Latin America. • U.S. precision medicine market share was about 65.1% of revenue of North America. • Germany precision medicine market share was more than $2.5 billion for 2015 and is predicted to contribute significantly to the growth of European industry. • China contributed more than 25.1% to APAC precision medicine market share for 2015 and is predicted to remain key region in future. • Key industry players profiled in the report include Roche Holdings AG, Qiagen, Pfizer, Medtronic, Source Precision Medicine Incorporation, Silicon Biosystems, Tepnel Pharma Services, Covance, Biocrates Life Sciences AG, Novartis, Nanostring Technologies, Laboratory Corporation of America Holdings, Quest Diagnostics, Teva Pharmaceuticals, Intomics, Ferrer InCode, Eagle Genomics Limited and Quest Diagnostics.

  5. Europe precision medicine market size, by application, 2013 - 2023 (USD Million)

  6. Browse Full Market Research Report On Precision Medicine Market @ http://bit.ly/2noIjey Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/671https://www.gminsights.com/request-sample/detail/49

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related